New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

The FDA has approved Yutrepia, an inhaled treprostinil formulation, for the treatment of PAH and PH-ILD, two forms of ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) ...

By providing practical information and tools to help healthcare professionals recognize the signs and symptoms of ILD and understand the diagnostic process, patients can be diagnosed earlier and ...

“I don’t leave monitoring [for progression] solely up to the pulmonologist,” particularly when caring for patients with early ILD related to CTD, who often have minimal symptoms and may not ...

These are a sign of sores on the lungs. If you have symptoms of interstitial lung disease but aren't thought to have COVID-19, your doctor will start by giving you a physical exam. They may also ...

Artificial intelligence (AI) is a branch of computer science developed in the 1950s to imitate the human ability for solving ...

With symptoms that often mimic other respiratory conditions, ILD is frequently misdiagnosed or unrecognized. However, in the Philippines, hope is in the horizon. Dr. Aileen Banzon of Philippine ...